195 related articles for article (PubMed ID: 20107716)
1. Fusidic acid resistant Staphylococcus aureus and skin disease.
Lomholt HB
Acta Derm Venereol; 2010; 90(1):4. PubMed ID: 20107716
[No Abstract] [Full Text] [Related]
2. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
[TBL] [Abstract][Full Text] [Related]
3. Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo.
Thum D; Seidl HP; Hein R; Ring J; Andres C; Mempel M
J Dtsch Dermatol Ges; 2013 Sep; 11(9):875-8. PubMed ID: 23621472
[No Abstract] [Full Text] [Related]
4. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
5. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Koning S; Thomas S; van der Wouden JC
Ned Tijdschr Geneeskd; 2003 Jan; 147(3):134; author reply 135. PubMed ID: 12577775
[No Abstract] [Full Text] [Related]
6. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Peeters KA; Mascini EM; Blok HE; Sanders CJ
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
[TBL] [Abstract][Full Text] [Related]
7. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
[No Abstract] [Full Text] [Related]
8. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
[TBL] [Abstract][Full Text] [Related]
9. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
Mitra A; Mohanraj M; Shah M
Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
[TBL] [Abstract][Full Text] [Related]
10. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
Weston VC; Boswell TC; Finch RG; Perkins W
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928
[No Abstract] [Full Text] [Related]
11. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
Owen SE; Cheesbrough JS
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053931
[No Abstract] [Full Text] [Related]
14. Fusidic acid cream for impetigo. Problem may be clinically important.
Stoddart B; Collyns T; Denton M
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053929
[No Abstract] [Full Text] [Related]
15. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
Vogel A; Lennon D; Best E; Leversha A
N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
[TBL] [Abstract][Full Text] [Related]
16. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
17. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.
Osterlund A; Eden T; Olsson-Liljequist B; Haeggman S; Kahlmeter G;
Scand J Infect Dis; 2002; 34(10):729-34. PubMed ID: 12477322
[TBL] [Abstract][Full Text] [Related]
18. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
Mason BW; Howard AJ
Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
[TBL] [Abstract][Full Text] [Related]
19. Resistance of Staphylococcus aureus to fusidic acid.
Peeters KA; Mascini EM; Sanders CJ
Int J Dermatol; 2004 Mar; 43(3):235-6. PubMed ID: 15009402
[No Abstract] [Full Text] [Related]
20. Impetigo with tense bulla on the dorsal hand.
Masu T; Suetake S; Aiba S; Okuyama R
J Dermatol; 2010 Jul; 37(7):683-4. PubMed ID: 20629839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
